1,271
Views
2
CrossRef citations to date
0
Altmetric
Articles

The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer – results from the SAMS trial

, , & ORCID Icon
Pages 318-322 | Received 10 Aug 2019, Accepted 24 Jun 2020, Published online: 14 Jul 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.